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Fig 1. Clavi syphilitici. Palmar hyperkeratotic plaques and
erythematous papules.
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autoimmune bullous diseases.
IgG recognition of extracellular domains of BP180
was also reported to be an early and crucial event in
development of BP, followed by ES events toward
intracytoplasmic domain of BP180 and BP230.5 Our
case showed IgG and IgA reactivity with various
extracellular domains of BP180, without reactivity
with BP230.
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syphilis
To the Editor: The clinical manifestations of syphilis,
often described as ‘‘the great imitator,’’ are varied and
may be neglected or confused with other diseases.1Open access under CC BY-NC-ND license.Furthermore, in patients with human immunodefi-
ciency virus (HIV), infections often exhibit unusual
features.2
A 24-year-old manwas referred to our department
for a 6-month history of warty lesions on the palms
and soles, unresponsive to keratolytic treatment. He
reported having sex with men, 3 sexual partners
during the past year, and inconsistent condom use.
Latent syphilis andHIV infection had been diagnosed
4 years earlier after screening analysis and, at that
time, he was appropriately treated with penicillin.
Clinical examination revealed well-demarcated
hyperkeratotic plaques and some erythematous
macules and papules on the palms and on the soles
(Fig 1). Exudative pink papules were observed on
the scrotum and violet-brown macular plaques were
present in the perianal region.
A biopsy specimen of a palmar lesion demon-
strated hyperkeratosis and a dermal polymorphic
infiltrate with histiocytes, plasma cells, and lympho-
cytes. Warthin-Starry stain did not demonstrate
microorganisms, but polymerase chain reaction was
positive for Treponema pallidum in the skin lesion
sample. Histologic examination of the perianal le-
sionswas consistentwith the diagnosis of condyloma
acuminata. Routine laboratory tests were normal and
tests for hepatitis A, B, and Cwere negative. HIV viral
load was 50,990 copies/mL and CD4 cell count was
308 cell/mm3 (normal range: 500-1000 cells/mm3).
A positive Venereal Disease Research Laboratory
test (titer 1:32) and a reactive Treponema
pallidum particle agglutination assay were obtained,
supporting the diagnosis of secondary syphilis.
Treatment was performed with a single intramus-
cular dose of benzathine penicillin (2,400,000 U).
Rapid regression of palmoplantar and scrotal lesions
Fig 2. Clavi syphilitici. Clinical appearance of palmar
lesions 1 month after penicillin treatment.
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The patient underwent proctologic examination,
which showed no further alterations in addition to
perianal condyloma acuminata, and cryosurgery of
those lesions was performed.
The multiple and atypical manifestations of
secondary syphilis in patients with HIV may result
in a misdiagnosis and inappropriate treatment.
In the literature, there are few reports of palmar
and plantar hyperkeratotic lesions of secondary
syphilis,3,4 some of which can mimic and be
confused with viral warts or calluses, classically
known as clavi syphilitici.5
In the described case, the combination of
palmar-plantar lesions, detection of Treponema
pallidum by molecular biology, positive serology
for syphilis, and rapid response to treatment with
penicillin was consistent with a diagnosis of sec-
ondary syphilis.
We present this case to illustrate a rare and
potentially confounding clinical manifestation of
syphilis, a disease that is still very present in medical
practice. We also intend to emphasize that the
acquisition of another sexually transmitted infection
(STI) by a patient with HIV is a public health problem
because it means the maintenance of risk behaviors
that enhance the transmission of these diseases. For
the patient, the infection with an STI is a risk factor
for other STIs, so in individuals with HIV, syphilis
should be included in the differential diagnosis of
new skin and mucosal lesions or those unresponsive
to conventional therapy.
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http://dx.doi.org/10.1016/j.jaad.2013.09.025A case of lipoatrophy following quadrivalent
human papillomavirus vaccine administration
To the Editor: Lipoatrophy is a localized loss of
subcutaneous adipose tissue without significant
inflammation.1 Acquired forms result from physical
trauma (cold, trauma, factitious insults) or from
contact with noxious chemicals.2 It is a common
reaction at the level of injection sites and could
appear at a distant site months or years after the
injection.
Several drugs have been implicated, including
insulin and insulin analogs in diabetes, glatiramer
acetate in multiple sclerosis, corticosteroids, vaso-
pressin, antibiotics, human growth hormone, iron
dextran, diphtheria-pertussis-tetanus immunization
serum, and antihistamines.1
We report a case of lipoatrophy that could be
associated with injection of prophylactic quadriva-
lent human papillomavirus vaccine Gardasil.
A 27-year-old woman presented to the derma-
tology clinic with a circular depression on her right
arm without any local symptoms or previous inflam-
mation. She had no medical problems and was not
taking any medication. She reported a history of 3
intramuscular Gardasil injections on a 0-, 2-, and
6-month-schedule in the same arm, with the last
injection given 9 months before the appearance of
the lesion. The patient denied any other injection
( foreign body or steroids) or trauma to the involved
arm. Physical examination revealed a soft, non-
tender, 8- 3 5-cm skin depression. The patient also
